Literature DB >> 20818784

Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies?

Kenneth L Tyler.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20818784     DOI： 10.1002/ana.22185

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  10 in total

1.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

2.  Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.

Authors:  Gang Chen; Leonid Gorelik; Kenneth J Simon; Alevtina Pavlenco; Anne Cheung; Margot Brickelmaier; Ling Ling Chen; Ping Jin; Paul H Weinreb; Sachdev S Sidhu
Journal:  MAbs       Date:  2015-04-16       Impact factor: 5.857

3.  Combined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponses.

Authors:  William H Kitchens; Divya Haridas; Maylene E Wagener; Mingqing Song; Mandy L Ford
Journal:  Transplantation       Date:  2012-05-27       Impact factor: 4.939

4.  Progressive multifocal leukoencephalopathy (PML) after transplantation.

Authors:  Christina Nguyen; Ron Shapiro
Journal:  Pediatr Transplant       Date:  2011-01-17

Review 5.  Monoclonal antibody therapy-associated neurological disorders.

Authors:  Xavier Bosch; Albert Saiz; Manuel Ramos-Casals
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

6.  Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.

Authors:  David B Clifford; Beau Ances; Craig Costello; Shari Rosen-Schmidt; Magnus Andersson; Deborah Parks; Arie Perry; Raju Yerra; Robert Schmidt; Enrique Alvarez; Kenneth L Tyler
Journal:  Arch Neurol       Date:  2011-05-09

7.  Integrin antagonists for transplant immunosuppression: panacea or peril?

Authors:  William H Kitchens; Christian P Larsen; Mandy L Ford
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

8.  New insights into neuromyelitis optica.

Authors:  Woojun Kim; Su-Hyun Kim; Ho Jin Kim
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

Review 9.  Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors.

Authors:  Maria Chiara G Monaco; Eugene O Major
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

10.  Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.

Authors:  Maria Meira; Claudia Sievers; Francine Hoffmann; Aiden Haghikia; Maria Rasenack; Bernhard F Décard; Jens Kuhle; Tobias Derfuss; Ludwig Kappos; Raija L P Lindberg
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.